ARTICLES BY THIS AUTHOR
- 2/11/2021
IQVIA’s Long offers view of pharmaceutical industry amid COVID pandemic
IQVIA's Doug Long weighed in on the pharmaceutical market amid COVID-19 during a DSN webinar held Thursday. - 2/12/2021
Sandoz to acquire GSK's antibiotics cephalosporin business
Sandoz is acquiring GSK’s cephalosporin antibiotics business, including three established brands, Zinnat, Zinacef and Fortum. - 2/12/2021
Akorn obtains FDA green light for loteprednol etabonate ophthalmic gel
Loteprednol etabonate ophthalmic gel 0.5% had a market value of approximately $35 million for the 12 months ended December 2020, according to IQVIA. - 2/11/2021
Glenmark gets FDA nod for generic Cleocin T Gel
The Cleocin T Gel had a market value of approximately $73.8 million for the 12 months ended December 2020, according to IQVIA. - 2/10/2021
APhA names Shannon Morrison CFO
Shannon Morrison, succeeds Joe Janela as CFO, who is retiring after 11 years at APhA. - 2/10/2021
Regeneron, Sanofi get FDA nod for new indication for Libtayo
Libtayo is now approved for both advanced cutaneous squamous cell and basal cell carcinomas. - 2/10/2021
Glenmark obtains FDA green light for generic Qudexy
Qudexy XR capsules had a market value of about $120.8 million for the 12 month period endedDecember 2020, according to IQVIA. - 2/9/2021
APhA Foundation awards student scholarships
Nineteen pharmacy students have been awarded the 2021 American Pharmacists Association Foundation Student Scholarship based on their academic achievements and leadership skills. - 2/9/2021
Lupin gets FDA nod for generic Kerydin
Tavaborole topical solution had a market value of roughly $76 million, according to IQVIA December 2020 data. - 2/9/2021
Virtual roundtable: State of the generics industry
Executives from leading generics firms weigh in on what the future holds for the industry and what hurdles will have to be overcome.